Target intelligence / Profile preview

G-protein-coupled inwardly-rectifying potassium channel (GIRK) (GIRK)

Target
GIRK
Molecular classification
Ion channel, Inwardly-rectifying potassium channel, G protein-coupled effector
01

Overview

G-protein-coupled inwardly-rectifying potassium (GIRK) channels are a family of potassium channels (Kir3.1 to Kir3.4) that play a fundamental role in controlling cellular excitability. These channels are uniquely activated by the direct binding of G-protein beta-gamma (Gβγ) subunits following the stimulation of Gi/o-coupled G protein-coupled receptors (GPCRs) such as muscarinic M2, GABA-B, and opioid receptors (Lüscher & Slesinger, 2010, Nature Reviews Neuroscience). In the heart, GIRK channels (specifically GIRK1/GIRK4 heteromers) mediate the vagal slowing of the heart rate, while in the brain, they contribute to inhibitory postsynaptic potentials and regulate neuronal firing (Hibino et al., 2010, Physiological Reviews). Dysfunction or mutations in GIRK channels are implicated in various pathologies, including atrial fibrillation, epilepsy, and primary aldosteronism (Whorton & MacKinnon, 2013, Cell). Because of their widespread involvement in neurotransmission and cardiac rhythm, they are considered promising therapeutic targets for treating arrhythmias and neuropsychiatric conditions (Nimitvilai et al., 2018, Journal of Neuroscience Research).

Other names
Kir3 channelInwardly rectifying potassium channel subfamily JMuscarinic-gated potassium channelKCNJ3KCNJ5KCNJ6KCNJ9
02

Mechanism of action

Activation by G-protein beta-gamma (Gβγ) subunits released from Gi/o-coupled G protein-coupled receptors (GPCRs), resulting in potassium efflux and membrane hyperpolarization.

03

Biological functions

Signal transductionRegulation of membrane potentialSynaptic transmissionHeart rate regulationCellular hyperpolarization
04

Disease associations

Atrial fibrillationEpilepsyParkinson's diseaseDrug addictionPrimary aldosteronismKeppen-Lubinsky syndromeChronic pain
05

Safety considerations

Cardiac arrhythmia riskNeurological side effectsHypotensionPotential for abuse/addiction modulation
06

Interacting drugs

Ethanol

7 more in the full profile.

07

Biomarkers

KCNJ5 somatic mutationsGIRK4 expression levelsKCNJ6 genetic variants

Beyond the preview

Go deeper on G-protein-coupled inwardly-rectifying potassium channel (GIRK) (GIRK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-protein-coupled inwardly-rectifying potassium channel (GIRK) (GIRK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call